<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39460363</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Impact of Infections During Pregnancy on Transplacental Antibody Transfer.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1199</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12101199</ELocationID><Abstract><AbstractText>Vaccination in pregnancy is important to protect the mother and fetus from infectious diseases. The transfer of maternal antibodies across the placenta during pregnancy can continue to protect the neonate for several months after birth while the neonatal adaptive immune system develops. Several pathogens have been shown to impair the transplacental transfer of maternal antibodies, including human immunodeficiency virus, malaria, the severe acute respiratory syndrome coronavirus 2, and cytomegalovirus. This review discusses the mechanisms contributing to decreased transplacental antibody transfer in the setting of maternal infections, such as changes in antibody glycosylation profile, maternal hypergammaglobulinemia, and placental injury. The frequency of epidemics is increasing, and pregnant people are more likely to become exposed to novel pathogens now than they were in the past. Understanding the mechanisms by which infectious diseases impair maternal-fetal antibody transfer is important for pandemic preparedness to maximize the impact of maternal vaccination for child health.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Coler</LastName><ForeName>Celeste</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King-Nakaoka</LastName><ForeName>Elana</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Every</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chima</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, Seattle, WA 98105, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vong</LastName><ForeName>Ashley</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Rosario</LastName><ForeName>Briana</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>VanAbel</LastName><ForeName>Roslyn</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>College of Pharmacy, University of Michigan, Ann Arbor, MI 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams Waldorf</LastName><ForeName>Kristina M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0002-6939-7224</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Global Health, University of Washington, Seattle, WA 98105, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>5R01AI143265-05A1</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R01AI176777-01A1</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5R01AI164588-04A1</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">antibody</Keyword><Keyword MajorTopicYN="N">fetus</Keyword><Keyword MajorTopicYN="N">malaria</Keyword><Keyword MajorTopicYN="N">placenta</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39460363</ArticleId><ArticleId IdType="pmc">PMC11512415</ArticleId><ArticleId IdType="doi">10.3390/vaccines12101199</ArticleId><ArticleId IdType="pii">vaccines12101199</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Niewiesk S. Maternal antibodies: Clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front. Immunol. 2014;5:446. doi: 10.3389/fimmu.2014.00446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00446</ArticleId><ArticleId IdType="pmc">PMC4165321</ArticleId><ArticleId IdType="pubmed">25278941</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd B.D. Neonatal T Cells: A Reinterpretation. Annu. Rev. Immunol. 2020;38:229–247. doi: 10.1146/annurev-immunol-091319-083608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-091319-083608</ArticleId><ArticleId IdType="pmc">PMC7369171</ArticleId><ArticleId IdType="pubmed">31928469</ArticleId></ArticleIdList></Reference><Reference><Citation>Callender M., Harvill E.T. Maternal vaccination: Shaping the neonatal response to pertussis. Front. Immunol. 2023;14:1210580. doi: 10.3389/fimmu.2023.1210580.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1210580</ArticleId><ArticleId IdType="pmc">PMC10374427</ArticleId><ArticleId IdType="pubmed">37520565</ArticleId></ArticleIdList></Reference><Reference><Citation>Bento A.I., Rohani P. Forecasting Epidemiological Consequences of Maternal Immunization. Clin. Infect. Dis. 2016;63:S205–S212. doi: 10.1093/cid/ciw557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciw557</ArticleId><ArticleId IdType="pmc">PMC5106624</ArticleId><ArticleId IdType="pubmed">27838674</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapuan S., Andrews N., Hallis B., Hole L., Jones C.E., Matheson M., Miller E., Snape M.D., Heath P.T. An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-containing vaccines or received no pertussis-containing vaccine in pregnancy in England. Vaccine. 2022;40:7050–7056. doi: 10.1016/j.vaccine.2022.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.10.005</ArticleId><ArticleId IdType="pubmed">36272877</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S  Centers for Disease Control and Prevention. Guidelines for Vaccinating Pregnant Persons.  [(accessed on 25 August 2024)]; Available online:  https://www.cdc.gov/vaccines-pregnancy/hcp/vaccination-guidelines/index.html.</Citation></Reference><Reference><Citation>ACOG Committee Opinion No. 741: Maternal Immunization. Obstet. Gynecol. 2018;131:e214–e217. doi: 10.1097/AOG.0000000000002662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000002662</ArticleId><ArticleId IdType="pubmed">29794683</ArticleId></ArticleIdList></Reference><Reference><Citation>ACOG Committee Opinion No. 732: Influenza Vaccination During Pregnancy. Obstet. Gynecol. 2018;131:e109–e114. doi: 10.1097/AOG.0000000000002588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000002588</ArticleId><ArticleId IdType="pubmed">29578985</ArticleId></ArticleIdList></Reference><Reference><Citation>Donders G.G.G., Grinceviciene S., Haldre K., Lonnee-Hoffmann R., Donders F., Tsiakalos A., Adriaanse A., Martinez de Oliveira J., Ault K., Mendling W., et al. ISIDOG Consensus Guidelines on COVID-19 Vaccination for Women before, during and after Pregnancy. J. Clin. Med. 2021;10:2902. doi: 10.3390/jcm10132902.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132902</ArticleId><ArticleId IdType="pmc">PMC8268868</ArticleId><ArticleId IdType="pubmed">34209801</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins I., Louwen F., Ayres-de-Campos D., Mahmood T. EBCOG position statement on COVID-19 vaccination for pregnant and breastfeeding women. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021;262:256–258. doi: 10.1016/j.ejogrb.2021.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2021.05.021</ArticleId><ArticleId IdType="pmc">PMC8120807</ArticleId><ArticleId IdType="pubmed">34020833</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetto C., Carosso A., Corezzi M., Zotti C.M. EBCOG position statement: Vaccination in pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2019;240:375–376. doi: 10.1016/j.ejogrb.2019.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejogrb.2019.04.022</ArticleId><ArticleId IdType="pubmed">31088698</ArticleId></ArticleIdList></Reference><Reference><Citation>Horgan R., Hughes B.L., Waller J., Hage Diab Y., Saade G. Understanding New Recommendations for Respiratory Syncytial Virus Prevention in Pregnancy. Obstet. Gynecol. 2024;143:484–490. doi: 10.1097/AOG.0000000000005524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000005524</ArticleId><ArticleId IdType="pubmed">38330405</ArticleId></ArticleIdList></Reference><Reference><Citation>Marani M., Katul G.G., Pan W.K., Parolari A.J. Intensity and frequency of extreme novel epidemics. Proc. Natl. Acad. Sci. USA. 2021;118:e2105482118. doi: 10.1073/pnas.2105482118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2105482118</ArticleId><ArticleId IdType="pmc">PMC8536331</ArticleId><ArticleId IdType="pubmed">34426498</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegrist C.A., Aspinall R. B-cell responses to vaccination at the extremes of age. Nat. Rev. Immunol. 2009;9:185–194. doi: 10.1038/nri2508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2508</ArticleId><ArticleId IdType="pubmed">19240757</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmeira P., Quinello C., Silveira-Lessa A.L., Zago C.A., Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies. Clin. Dev. Immunol. 2012;2012:985646. doi: 10.1155/2012/985646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/985646</ArticleId><ArticleId IdType="pmc">PMC3251916</ArticleId><ArticleId IdType="pubmed">22235228</ArticleId></ArticleIdList></Reference><Reference><Citation>Simister N.E., Rees A.R. Isolation and characterization of an Fc receptor from neonatal rat small intestine. Eur. J. Immunol. 1985;15:733–738. doi: 10.1002/eji.1830150718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830150718</ArticleId><ArticleId IdType="pubmed">2988974</ArticleId></ArticleIdList></Reference><Reference><Citation>Firan M., Bawdon R., Radu C., Ober R.J., Eaken D., Antohe F., Ghetie V., Ward E.S. The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans. Int. Immunol. 2001;13:993–1002. doi: 10.1093/intimm/13.8.993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/13.8.993</ArticleId><ArticleId IdType="pubmed">11470769</ArticleId></ArticleIdList></Reference><Reference><Citation>Simister N.E., Mostov K.E. An Fc receptor structurally related to MHC class I antigens. Nature. 1989;337:184–187. doi: 10.1038/337184a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/337184a0</ArticleId><ArticleId IdType="pubmed">2911353</ArticleId></ArticleIdList></Reference><Reference><Citation>Israel E.J., Wilsker D.F., Hayes K.C., Schoenfeld D., Simister N.E. Increased clearance of IgG in mice that lack beta 2-microglobulin: Possible protective role of FcRn. Immunology. 1996;89:573–578. doi: 10.1046/j.1365-2567.1996.d01-775.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2567.1996.d01-775.x</ArticleId><ArticleId IdType="pmc">PMC1456584</ArticleId><ArticleId IdType="pubmed">9014824</ArticleId></ArticleIdList></Reference><Reference><Citation>Simister N.E., Story C.M. Human placental Fc receptors and the transmission of antibodies from mother to fetus. J. Reprod. Immunol. 1997;37:1–23. doi: 10.1016/S0165-0378(97)00068-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-0378(97)00068-5</ArticleId><ArticleId IdType="pubmed">9501287</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn D.E., Bjorkman P.J. Structural basis of pH-dependent antibody binding by the neonatal Fc receptor. Structure. 1998;6:63–73. doi: 10.1016/S0969-2126(98)00008-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0969-2126(98)00008-2</ArticleId><ArticleId IdType="pubmed">9493268</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodewald R. pH-dependent binding of immunoglobulins to intestinal cells of the neonatal rat. J. Cell Biol. 1976;71:666–669. doi: 10.1083/jcb.71.2.666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.71.2.666</ArticleId><ArticleId IdType="pmc">PMC2109747</ArticleId><ArticleId IdType="pubmed">11223</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristoffersen E.K. Human placental Fc gamma-binding proteins in the maternofetal transfer of IgG. APMIS Suppl. 1996;64:5–36. doi: 10.1111/j.1600-0463.1996.tb05583.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0463.1996.tb05583.x</ArticleId><ArticleId IdType="pubmed">8944053</ArticleId></ArticleIdList></Reference><Reference><Citation>Simister N.E., Story C.M., Chen H.L., Hunt J.S. An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta. Eur. J. Immunol. 1996;26:1527–1531. doi: 10.1002/eji.1830260718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830260718</ArticleId><ArticleId IdType="pubmed">8766556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ober R.J., Martinez C., Lai X., Zhou J., Ward E.S. Exocytosis of IgG as mediated by the receptor, FcRn: An analysis at the single-molecule level. Proc. Natl. Acad. Sci. USA. 2004;101:11076–11081. doi: 10.1073/pnas.0402970101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402970101</ArticleId><ArticleId IdType="pmc">PMC503743</ArticleId><ArticleId IdType="pubmed">15258288</ArticleId></ArticleIdList></Reference><Reference><Citation>Radulescu L., Antohe F., Jinga V., Ghetie V., Simionescu M. Neonatal Fc receptors discriminates and monitors the pathway of native and modified immunoglobulin G in placental endothelial cells. Hum. Immunol. 2004;65:578–585. doi: 10.1016/j.humimm.2004.02.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2004.02.029</ArticleId><ArticleId IdType="pubmed">15219377</ArticleId></ArticleIdList></Reference><Reference><Citation>Akilesh S., Petkova S., Sproule T.J., Shaffer D.J., Christianson G.J., Roopenian D. The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease. J. Clin. Investig. 2004;113:1328–1333. doi: 10.1172/JCI18838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI18838</ArticleId><ArticleId IdType="pmc">PMC398424</ArticleId><ArticleId IdType="pubmed">15124024</ArticleId></ArticleIdList></Reference><Reference><Citation>Landor M. Maternal-fetal transfer of immunoglobulins. Ann. Allergy Asthma Immunol. 1995;74:279–283. quiz 284.</Citation><ArticleIdList><ArticleId IdType="pubmed">7719885</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoko B.J., Wesumperuma H.L., Fern J., Yamuah L.K., Hart C.A. The transplacental transfer of IgG subclasses: Influence of prematurity and low birthweight in the Gambian population. Ann. Trop. Paediatr. 2002;22:325–332. doi: 10.1179/027249302125001985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/027249302125001985</ArticleId><ArticleId IdType="pubmed">12530282</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berg J.P., Westerbeek E.A., Berbers G.A., van Gageldonk P.G., van der Klis F.R., van Elburg R.M. Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants. Pediatr. Infect. Dis. J. 2010;29:801–805. doi: 10.1097/INF.0b013e3181dc4f77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e3181dc4f77</ArticleId><ArticleId IdType="pubmed">20803841</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek A., Sager R., Kuhn P., Nicolaides K.H., Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am. J. Reprod. Immunol. 1996;36:248–255. doi: 10.1111/j.1600-0897.1996.tb00172.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0897.1996.tb00172.x</ArticleId><ArticleId IdType="pubmed">8955500</ArticleId></ArticleIdList></Reference><Reference><Citation>Jauniaux E., Jurkovic D., Gulbis B., Liesnard C., Lees C., Campbell S. Materno-fetal immunoglobulin transfer and passive immunity during the first trimester of human pregnancy. Hum. Reprod. 1995;10:3297–3300. doi: 10.1093/oxfordjournals.humrep.a135906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.humrep.a135906</ArticleId><ArticleId IdType="pubmed">8822462</ArticleId></ArticleIdList></Reference><Reference><Citation>Medesan C., Matesoi D., Radu C., Ghetie V., Ward E.S. Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1. J. Immunol. 1997;158:2211–2217. doi: 10.4049/jimmunol.158.5.2211.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.158.5.2211</ArticleId><ArticleId IdType="pubmed">9036967</ArticleId></ArticleIdList></Reference><Reference><Citation>Clements T., Rice T.F., Vamvakas G., Barnett S., Barnes M., Donaldson B., Jones C.E., Kampmann B., Holder B. Update on Transplacental Transfer of IgG Subclasses: Impact of Maternal and Fetal Factors. Front. Immunol. 2020;11:1920. doi: 10.3389/fimmu.2020.01920.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01920</ArticleId><ArticleId IdType="pmc">PMC7516031</ArticleId><ArticleId IdType="pubmed">33013843</ArticleId></ArticleIdList></Reference><Reference><Citation>Stach S.C., Brizot M.L., Liao A.W., Palmeira P., Francisco R.P., Carneiro-Sampaio M.M., Zugaib M. Placental transfer of IgG antibodies specific to Klebsiella and Pseudomonas LPS and to group B Streptococcus in twin pregnancies. Scand. J. Immunol. 2015;81:135–141. doi: 10.1111/sji.12258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12258</ArticleId><ArticleId IdType="pubmed">25441088</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams P.J., Arkwright P.D., Rudd P., Scragg I.G., Edge C.J., Wormald M.R., Rademacher T.W. Short communication: Selective placental transport of maternal IgG to the fetus. Placenta. 1995;16:749–756. doi: 10.1016/0143-4004(95)90018-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0143-4004(95)90018-7</ArticleId><ArticleId IdType="pubmed">8710805</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa-Carvalho B.T., Vieria H.M., Dimantas R.B., Arslanian C., Naspitz C.K., Sole D., Carneiro-Sampaio M.M. Transfer of IgG subclasses across placenta in term and preterm newborns. Braz. J. Med. Biol. Res. 1996;29:201–204.</Citation><ArticleIdList><ArticleId IdType="pubmed">8731349</ArticleId></ArticleIdList></Reference><Reference><Citation>Black C.M., Plikaytis B.D., Wells T.W., Ramirez R.M., Carlone G.M., Chilmonczyk B.A., Reimer C.B. Two-site immunoenzymometric assays for serum IgG subclass infant/maternal ratios at full-term. J. Immunol. Methods. 1988;106:71–81. doi: 10.1016/0022-1759(88)90273-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-1759(88)90273-6</ArticleId><ArticleId IdType="pubmed">3276788</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza E.G., Hara C.C., Fagundes D.L., de Queiroz A.A., Morceli G., Calderon I.M., Franca E.L., Honorio-Franca A.C. Maternal-Foetal Diabetes Modifies Neonatal Fc Receptor Expression on Human Leucocytes. Scand. J. Immunol. 2016;84:237–244. doi: 10.1111/sji.12466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12466</ArticleId><ArticleId IdType="pubmed">27469170</ArticleId></ArticleIdList></Reference><Reference><Citation>Einarsdottir H.K., Stapleton N.M., Scherjon S., Andersen J.T., Rispens T., van der Schoot C.E., Vidarsson G. On the perplexingly low rate of transport of IgG2 across the human placenta. PLoS ONE. 2014;9:e108319. doi: 10.1371/journal.pone.0108319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0108319</ArticleId><ArticleId IdType="pmc">PMC4177109</ArticleId><ArticleId IdType="pubmed">25251461</ArticleId></ArticleIdList></Reference><Reference><Citation>Lostal Gracia M.I., Larrad Mur L., Perez Gonzalez J.M. IgG subclasses: Placental transfer in the full-term neonate and their evolution during the first 3 months of life. An. Esp. Pediatr. 1993;38:503–508.</Citation><ArticleIdList><ArticleId IdType="pubmed">8368678</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashira S., Okitsu-Negishi S., Yoshino K. Placental transfer of IgG subclasses in a Japanese population. Pediatr. Int. 2000;42:337–342. doi: 10.1046/j.1442-200x.2000.01245.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1442-200x.2000.01245.x</ArticleId><ArticleId IdType="pubmed">10986861</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoko B.J., Wesumperuma L.H., Ota M.O., Pinder M., Banya W., Gomez S.F., McAdam K.P., Hart A.C. The influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural West African population. J. Infect. Dis. 2001;184:627–632. doi: 10.1086/322808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/322808</ArticleId><ArticleId IdType="pubmed">11494168</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitcher-Wilmott R.W., Hindocha P., Wood C.B. The placental transfer of IgG subclasses in human pregnancy. Clin. Exp. Immunol. 1980;41:303–308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1537014</ArticleId><ArticleId IdType="pubmed">7438556</ArticleId></ArticleIdList></Reference><Reference><Citation>Merbl Y., Zucker-Toledano M., Quintana F.J., Cohen I.R. Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. J. Clin. Investig. 2007;117:712–718. doi: 10.1172/JCI29943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI29943</ArticleId><ArticleId IdType="pmc">PMC1804342</ArticleId><ArticleId IdType="pubmed">17332892</ArticleId></ArticleIdList></Reference><Reference><Citation>Gata-Garcia A., Diamond B. Maternal Antibody and ASD: Clinical Data and Animal Models. Front. Immunol. 2019;10:1129. doi: 10.3389/fimmu.2019.01129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01129</ArticleId><ArticleId IdType="pmc">PMC6547809</ArticleId><ArticleId IdType="pubmed">31191521</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.Y., Huerta P.T., Zhang J., Kowal C., Bertini E., Volpe B.T., Diamond B. Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat. Med. 2009;15:91–96. doi: 10.1038/nm.1892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1892</ArticleId><ArticleId IdType="pmc">PMC2615794</ArticleId><ArticleId IdType="pubmed">19079257</ArticleId></ArticleIdList></Reference><Reference><Citation>ACOG Practice Bulletin No. 192: Management of Alloimmunization During Pregnancy. Obstet. Gynecol. 2018;131:e82–e90. doi: 10.1097/AOG.0000000000002528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000002528</ArticleId><ArticleId IdType="pubmed">29470342</ArticleId></ArticleIdList></Reference><Reference><Citation>van Trotsenburg A.S.P. Management of neonates born to mothers with thyroid dysfunction, and points for attention during pregnancy. Best Pract. Res. Clin. Endocrinol. Metab. 2020;34:101437. doi: 10.1016/j.beem.2020.101437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beem.2020.101437</ArticleId><ArticleId IdType="pubmed">32651060</ArticleId></ArticleIdList></Reference><Reference><Citation>Hon K.L., Leung A.K. Neonatal lupus erythematosus. Autoimmune Dis. 2012;2012:301274. doi: 10.1155/2012/301274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/301274</ArticleId><ArticleId IdType="pmc">PMC3437607</ArticleId><ArticleId IdType="pubmed">22973504</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  HIV—Estimated Percentage of Pregnant Women Living with HIV Who Received Antiretrovirals for Preventing Mother-to-Child Transmission.  [(accessed on 27 August 2024)].  Available online:  https://www.who.int/data/gho/data/indicators/indicator-details/GHO/estimated-percentage-of-pregnant-women-living-with-hiv-who-received-antiretrovirals-for-preventing-mother-to-child-transmission#:~:text=Globally%2C%20there%20were%201.2%20million,mother%2Dto%2Dchild%20transmission.</Citation></Reference><Reference><Citation>Abu-Raya B., Kollmann T.R., Marchant A., MacGillivray D.M. The Immune System of HIV-Exposed Uninfected Infants. Front. Immunol. 2016;7:383. doi: 10.3389/fimmu.2016.00383.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00383</ArticleId><ArticleId IdType="pmc">PMC5039172</ArticleId><ArticleId IdType="pubmed">27733852</ArticleId></ArticleIdList></Reference><Reference><Citation>Dauby N., Gagneux-Brunon A., Martin C., Mussi-Pinhata M.M., Goetghebuer T. Maternal immunization in women living with HIV. AIDS. 2024;38:137–144. doi: 10.1097/QAD.0000000000003758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0000000000003758</ArticleId><ArticleId IdType="pubmed">38116721</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangor Z., Nunes M.C., Kwatra G., Lala S.G., Madhi S.A. Vaccination of HIV-infected pregnant women: Implications for protection of their young infants. Trop. Dis. Travel. Med. Vaccines. 2017;3:1. doi: 10.1186/s40794-016-0044-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40794-016-0044-7</ArticleId><ArticleId IdType="pmc">PMC5530931</ArticleId><ArticleId IdType="pubmed">28883971</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan A.T., Bonawitz R., Gill C.J., Thea D.M., Kleinman M., Useem J., Garrison L., Ceccarelli R., Udokwu C., Long L., et al. A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared with HIV-unexposed uninfected infants and children. AIDS. 2016;30:2351–2360. doi: 10.1097/QAD.0000000000001211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0000000000001211</ArticleId><ArticleId IdType="pubmed">27456985</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan A.T., Bonawitz R., Gill C.J., Thea D.M., Kleinman M., Long L., McCallum C., Fox M.P. A Meta-analysis Assessing Diarrhea and Pneumonia in HIV-Exposed Uninfected Compared with HIV-Unexposed Uninfected Infants and Children. J. Acquir. Immune Defic. Syndr. 2019;82:1–8. doi: 10.1097/QAI.0000000000002097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAI.0000000000002097</ArticleId><ArticleId IdType="pmc">PMC8214449</ArticleId><ArticleId IdType="pubmed">31408450</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Raya B., Smolen K.K., Willems F., Kollmann T.R., Marchant A. Transfer of Maternal Antimicrobial Immunity to HIV-Exposed Uninfected Newborns. Front. Immunol. 2016;7:338. doi: 10.3389/fimmu.2016.00338.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00338</ArticleId><ArticleId IdType="pmc">PMC5005931</ArticleId><ArticleId IdType="pubmed">27630640</ArticleId></ArticleIdList></Reference><Reference><Citation>Taton M., Willems F., Widomski C., Georges D., Martin C., Jiang Y., Renard K., Konopnicki D., Cogan A., Necsoi C., et al. HIV-related immune activation attenuates polyfunctional IgG and memory B-cell responses to Tdap immunization during pregnancy. EBioMedicine. 2024;104:105179. doi: 10.1016/j.ebiom.2024.105179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2024.105179</ArticleId><ArticleId IdType="pmc">PMC11192781</ArticleId><ArticleId IdType="pubmed">38848615</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans C., Jones C.E., Prendergast A.J. HIV-exposed, uninfected infants: New global challenges in the era of paediatric HIV elimination. Lancet Infect. Dis. 2016;16:e92–e107. doi: 10.1016/S1473-3099(16)00055-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(16)00055-4</ArticleId><ArticleId IdType="pubmed">27049574</ArticleId></ArticleIdList></Reference><Reference><Citation>Afran L., Garcia Knight M., Nduati E., Urban B.C., Heyderman R.S., Rowland-Jones S.L. HIV-exposed uninfected children: A growing population with a vulnerable immune system? Clin. Exp. Immunol. 2014;176:11–22. doi: 10.1111/cei.12251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12251</ArticleId><ArticleId IdType="pmc">PMC3958150</ArticleId><ArticleId IdType="pubmed">24325737</ArticleId></ArticleIdList></Reference><Reference><Citation>de Moraes-Pinto M.I., Almeida A.C., Kenj G., Filgueiras T.E., Tobias W., Santos A.M., Carneiro-Sampaio M.M., Farhat C.K., Milligan P.J., Johnson P.M., et al. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J. Infect. Dis. 1996;173:1077–1084. doi: 10.1093/infdis/173.5.1077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/173.5.1077</ArticleId><ArticleId IdType="pubmed">8627057</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones C.E., Naidoo S., De Beer C., Esser M., Kampmann B., Hesseling A.C. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA. 2011;305:576–584. doi: 10.1001/jama.2011.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2011.100</ArticleId><ArticleId IdType="pubmed">21304083</ArticleId></ArticleIdList></Reference><Reference><Citation>Atwell J.E., Lutz C.S., Sparrow E.G., Feikin D.R. Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries. Vaccine. 2022;40:4361–4370. doi: 10.1016/j.vaccine.2022.06.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.06.034</ArticleId><ArticleId IdType="pmc">PMC9348036</ArticleId><ArticleId IdType="pubmed">35725783</ArticleId></ArticleIdList></Reference><Reference><Citation>Moir S., Fauci A.S. B cells in HIV infection and disease. Nat. Rev. Immunol. 2009;9:235–245. doi: 10.1038/nri2524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2524</ArticleId><ArticleId IdType="pmc">PMC2779527</ArticleId><ArticleId IdType="pubmed">19319142</ArticleId></ArticleIdList></Reference><Reference><Citation>Moir S., Fauci A.S. B-cell exhaustion in HIV infection: The role of immune activation. Curr. Opin. HIV AIDS. 2014;9:472–477. doi: 10.1097/COH.0000000000000092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/COH.0000000000000092</ArticleId><ArticleId IdType="pubmed">25023621</ArticleId></ArticleIdList></Reference><Reference><Citation>Moir S., Malaspina A., Ho J., Wang W., Dipoto A.C., O’Shea M.A., Roby G., Mican J.M., Kottilil S., Chun T.W., et al. Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease. J. Infect. Dis. 2008;197:572–579. doi: 10.1086/526789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/526789</ArticleId><ArticleId IdType="pubmed">18240953</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Global Malaria Programme . World Malaria Report 2023. World Health Organization; Geneva, Switzerland: 2023.</Citation></Reference><Reference><Citation>Zakama A.K., Ozarslan N., Gaw S.L. Placental Malaria. Curr. Trop. Med. Rep. 2020;7:162–171. doi: 10.1007/s40475-020-00213-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40475-020-00213-2</ArticleId><ArticleId IdType="pmc">PMC7493061</ArticleId><ArticleId IdType="pubmed">32953387</ArticleId></ArticleIdList></Reference><Reference><Citation>Atwell J.E., Thumar B., Robinson L.J., Tobby R., Yambo P., Ome-Kaius M., Siba P.M., Unger H.W., Rogerson S.J., King C.L., et al. Impact of Placental Malaria and Hypergammaglobulinemia on Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea. J. Infect. Dis. 2016;213:423–431. doi: 10.1093/infdis/jiv401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv401</ArticleId><ArticleId IdType="pmc">PMC4704666</ArticleId><ArticleId IdType="pubmed">26238686</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoko B.J., Wesuperuma L.H., Ota M.O., Banya W.A., Pinder M., Gomez F.S., Osinusi K., Hart A.C. Influence of placental malaria infection and maternal hypergammaglobulinaemia on materno-foetal transfer of measles and tetanus antibodies in a rural west African population. J. Health Popul. Nutr. 2001;19:59–65.</Citation><ArticleIdList><ArticleId IdType="pubmed">11503348</ArticleId></ArticleIdList></Reference><Reference><Citation>de Moraes-Pinto M.I., Verhoeff F., Chimsuku L., Milligan P.J., Wesumperuma L., Broadhead R.L., Brabin B.J., Johnson P.M., Hart C.A. Placental antibody transfer: Influence of maternal HIV infection and placental malaria. Arch. Dis. Child. Fetal Neonatal Ed. 1998;79:F202–F205. doi: 10.1136/fn.79.3.F202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/fn.79.3.F202</ArticleId><ArticleId IdType="pmc">PMC1720856</ArticleId><ArticleId IdType="pubmed">10194992</ArticleId></ArticleIdList></Reference><Reference><Citation>Brair M.E., Brabin B.J., Milligan P., Maxwell S., Hart C.A. Reduced transfer of tetanus antibodies with placental malaria. Lancet. 1994;343:208–209. doi: 10.1016/S0140-6736(94)90991-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(94)90991-1</ArticleId><ArticleId IdType="pubmed">7904669</ArticleId></ArticleIdList></Reference><Reference><Citation>Dechavanne C., Cottrell G., Garcia A., Migot-Nabias F. Placental Malaria: Decreased Transfer of Maternal Antibodies Directed to Plasmodium falciparum and Impact on the Incidence of Febrile Infections in Infants. PLoS ONE. 2015;10:e0145464. doi: 10.1371/journal.pone.0145464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0145464</ArticleId><ArticleId IdType="pmc">PMC4689360</ArticleId><ArticleId IdType="pubmed">26698578</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitworth J., Morgan D., Quigley M., Smith A., Mayanja B., Eotu H., Omoding N., Okongo M., Malamba S., Ojwiya A. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: A cohort study. Lancet. 2000;356:1051–1056. doi: 10.1016/S0140-6736(00)02727-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)02727-6</ArticleId><ArticleId IdType="pubmed">11009139</ArticleId></ArticleIdList></Reference><Reference><Citation>French N., Nakiyingi J., Lugada E., Watera C., Whitworth J.A., Gilks C.F. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS. 2001;15:899–906. doi: 10.1097/00002030-200105040-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002030-200105040-00010</ArticleId><ArticleId IdType="pubmed">11399962</ArticleId></ArticleIdList></Reference><Reference><Citation>Keen J., Serghides L., Ayi K., Patel S.N., Ayisi J., van Eijk A., Steketee R., Udhayakumar V., Kain K.C. HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med. 2007;4:e181. doi: 10.1371/journal.pmed.0040181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0040181</ArticleId><ArticleId IdType="pmc">PMC1880852</ArticleId><ArticleId IdType="pubmed">17535103</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso S., Vidal M., Ruiz-Olalla G., Gonzalez R., Jairoce C., Manaca M.N., Vazquez-Santiago M., Balcells R., Vala A., Ruperez M., et al. HIV infection and placental malaria reduce maternal transfer of multiple antimalarial antibodies in Mozambican women. J. Infect. 2021;82:45–57. doi: 10.1016/j.jinf.2021.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.02.024</ArticleId><ArticleId IdType="pubmed">33636218</ArticleId></ArticleIdList></Reference><Reference><Citation>Allotey J., Chatterjee S., Kew T., Gaetano A., Stallings E., Fernandez-Garcia S., Yap M., Sheikh J., Lawson H., Coomar D., et al. SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission: Living systematic review and meta-analysis. BMJ. 2022;376:e067696. doi: 10.1136/bmj-2021-067696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-067696</ArticleId><ArticleId IdType="pmc">PMC8924705</ArticleId><ArticleId IdType="pubmed">35296519</ArticleId></ArticleIdList></Reference><Reference><Citation>Raschetti R., Vivanti A.J., Vauloup-Fellous C., Loi B., Benachi A., De Luca D. Synthesis and systematic review of reported neonatal SARS-CoV-2 infections. Nat. Commun. 2020;11:5164. doi: 10.1038/s41467-020-18982-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18982-9</ArticleId><ArticleId IdType="pmc">PMC7566441</ArticleId><ArticleId IdType="pubmed">33060565</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z., Tong S. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;145:e20200702. doi: 10.1542/peds.2020-0702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-0702</ArticleId><ArticleId IdType="pubmed">32179660</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaherman V.J., Afshar Y., Boscardin W.J., Keller R.L., Mardy A.H., Prahl M.K., Phillips C.T., Asiodu I.V., Berghella V., Chambers B.D., et al. Infant Outcomes Following Maternal Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): First Report From the Pregnancy Coronavirus Outcomes Registry (PRIORITY) Study. Clin. Infect. Dis. 2021;73:e2810–e2813. doi: 10.1093/cid/ciaa1411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1411</ArticleId><ArticleId IdType="pmc">PMC7543372</ArticleId><ArticleId IdType="pubmed">32947612</ArticleId></ArticleIdList></Reference><Reference><Citation>Edlow A.G., Li J.Z., Collier A.Y., Atyeo C., James K.E., Boatin A.A., Gray K.J., Bordt E.A., Shook L.L., Yonker L.M., et al. Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic. JAMA Netw. Open. 2020;3:e2030455. doi: 10.1001/jamanetworkopen.2020.30455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.30455</ArticleId><ArticleId IdType="pmc">PMC7756241</ArticleId><ArticleId IdType="pubmed">33351086</ArticleId></ArticleIdList></Reference><Reference><Citation>Boettcher L.B., Metz T.D. Maternal and neonatal outcomes following SARS-CoV-2 infection. Semin. Fetal Neonatal Med. 2023;28:101428. doi: 10.1016/j.siny.2023.101428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.siny.2023.101428</ArticleId><ArticleId IdType="pmc">PMC10005973</ArticleId><ArticleId IdType="pubmed">37105860</ArticleId></ArticleIdList></Reference><Reference><Citation>Flannery D.D., Gouma S., Dhudasia M.B., Mukhopadhyay S., Pfeifer M.R., Woodford E.C., Briker S.M., Triebwasser J.E., Gerber J.S., Morris J.S., et al. Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection. JAMA Netw. Open. 2022;5:e2240993. doi: 10.1001/jamanetworkopen.2022.40993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.40993</ArticleId><ArticleId IdType="pmc">PMC9647482</ArticleId><ArticleId IdType="pubmed">36350652</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyers J., Windau A., Schmotzer C., Saade E., Noguez J., Stempak L., Zhang X. SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassays. Diagn. Microbiol. Infect. Dis. 2022;104:115803. doi: 10.1016/j.diagmicrobio.2022.115803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2022.115803</ArticleId><ArticleId IdType="pmc">PMC9420072</ArticleId><ArticleId IdType="pubmed">36162282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Esposito D., Kang Z., Lu J., Remaley A.T., De Giorgi V., Chen L.N., West K., Cao L. mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants. Sci. Rep. 2022;12:2628. doi: 10.1038/s41598-022-06629-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-06629-2</ArticleId><ArticleId IdType="pmc">PMC8850441</ArticleId><ArticleId IdType="pubmed">35173254</ArticleId></ArticleIdList></Reference><Reference><Citation>Atyeo C., Pullen K.M., Bordt E.A., Fischinger S., Burke J., Michell A., Slein M.D., Loos C., Shook L.L., Boatin A.A., et al. Compromised SARS-CoV-2-specific placental antibody transfer. Cell. 2021;184:628–642.e10. doi: 10.1016/j.cell.2020.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.027</ArticleId><ArticleId IdType="pmc">PMC7755577</ArticleId><ArticleId IdType="pubmed">33476549</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghai Z.H., Goudar S.S., Patel A., Saleem S., Dhaded S.M., Kavi A., Lalakia P., Naqvi F., Hibberd P.L., McClure E.M., et al. Gender variations in neonatal and early infant mortality in India and Pakistan: A secondary analysis from the Global Network Maternal Newborn Health Registry. Reprod. Health. 2020;17:178. doi: 10.1186/s12978-020-01028-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12978-020-01028-0</ArticleId><ArticleId IdType="pmc">PMC7745348</ArticleId><ArticleId IdType="pubmed">33334358</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury R., Taneja S., Mazumder S., Bhandari N., Strand T.A. Gender differences in infant survival: A secondary data analysis in rural North India. BMJ Open. 2017;7:e014179. doi: 10.1136/bmjopen-2016-014179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-014179</ArticleId><ArticleId IdType="pmc">PMC5724117</ArticleId><ArticleId IdType="pubmed">28801386</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal D., Galloway T.S., Bailey T.C., Mathews F. Elevated risk of stillbirth in males: Systematic review and meta-analysis of more than 30 million births. BMC Med. 2014;12:220. doi: 10.1186/s12916-014-0220-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-014-0220-4</ArticleId><ArticleId IdType="pmc">PMC4245790</ArticleId><ArticleId IdType="pubmed">25428603</ArticleId></ArticleIdList></Reference><Reference><Citation>Ao A., Erickson R.P., Winston R.M., Handyside A.H. Transcription of paternal Y-linked genes in the human zygote as early as the pronucleate stage. Zygote. 1994;2:281–287. doi: 10.1017/S0967199400002100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0967199400002100</ArticleId><ArticleId IdType="pubmed">8665158</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiffin G.J., Rieger D., Betteridge K.J., Yadav B.R., King W.A. Glucose and glutamine metabolism in pre-attachment cattle embryos in relation to sex and stage of development. J. Reprod. Fertil. 1991;93:125–132. doi: 10.1530/jrf.0.0930125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/jrf.0.0930125</ArticleId><ArticleId IdType="pubmed">1920281</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordt E.A., Shook L.L., Atyeo C., Pullen K.M., De Guzman R.M., Meinsohn M.C., Chauvin M., Fischinger S., Yockey L.J., James K., et al. Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses. Sci. Transl. Med. 2021;13:eabi7428. doi: 10.1126/scitranslmed.abi7428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abi7428</ArticleId><ArticleId IdType="pmc">PMC8784281</ArticleId><ArticleId IdType="pubmed">34664987</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartter H.K., Oyedele O.I., Dietz K., Kreis S., Hoffman J.P., Muller C.P. Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children. Pediatr. Infect. Dis. J. 2000;19:635–641. doi: 10.1097/00006454-200007000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-200007000-00010</ArticleId><ArticleId IdType="pubmed">10917222</ArticleId></ArticleIdList></Reference><Reference><Citation>Atwell J.E., Thumar B., Formica M.A., Robinson L.J., Walsh E.E., King C.L., Karron R.A. Hypergammaglobulinemia and Impaired Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea. Pediatr. Infect. Dis. J. 2019;38:e199–e202. doi: 10.1097/INF.0000000000002364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002364</ArticleId><ArticleId IdType="pubmed">31408055</ArticleId></ArticleIdList></Reference><Reference><Citation>Jallow S., Agosti Y., Kgagudi P., Vandecar M., Cutland C.L., Simoes E.A.F., Nunes M.C., Suchard M.S., Madhi S.A. Impaired Transplacental Transfer of Respiratory Syncytial Virus-neutralizing Antibodies in Human Immunodeficiency Virus-infected Versus -uninfected Pregnant Women. Clin. Infect. Dis. 2019;69:151–154. doi: 10.1093/cid/ciy1071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy1071</ArticleId><ArticleId IdType="pubmed">30561563</ArticleId></ArticleIdList></Reference><Reference><Citation>Babakhanyan A., Ekali G.L., Dent A., Kazura J., Nguasong J.T., Fodjo B.A.Y., Yuosembom E.K., Esemu L.F., Taylor D.W., Leke R.G.F. Maternal Human Immunodeficiency Virus-Associated Hypergammaglobulinemia Reduces Transplacental Transfer of Immunoglobulin G to Plasmodium falciparum Antigens in Cameroonian Neonates. Open Forum Infect. Dis. 2016;3:ofw092. doi: 10.1093/ofid/ofw092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofw092</ArticleId><ArticleId IdType="pmc">PMC4943556</ArticleId><ArticleId IdType="pubmed">28487863</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarpa R., Dell’Edera A., Felice C., Buso R., Muscianisi F., Finco Gambier R., Toffolo S., Grossi U., Giobbia M., Barberio G., et al. Impact of Hypogammaglobulinemia on the Course of COVID-19 in a Non-Intensive Care Setting: A Single-Center Retrospective Cohort Study. Front. Immunol. 2022;13:842643. doi: 10.3389/fimmu.2022.842643.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.842643</ArticleId><ArticleId IdType="pmc">PMC8960988</ArticleId><ArticleId IdType="pubmed">35359947</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane H.C., Masur H., Edgar L.C., Whalen G., Rook A.H., Fauci A.S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 1983;309:453–458. doi: 10.1056/NEJM198308253090803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198308253090803</ArticleId><ArticleId IdType="pubmed">6224088</ArticleId></ArticleIdList></Reference><Reference><Citation>De Milito A., Nilsson A., Titanji K., Thorstensson R., Reizenstein E., Narita M., Grutzmeier S., Sonnerborg A., Chiodi F. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood. 2004;103:2180–2186. doi: 10.1182/blood-2003-07-2375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-07-2375</ArticleId><ArticleId IdType="pubmed">14604962</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennewein M.F., Goldfarb I., Dolatshahi S., Cosgrove C., Noelette F.J., Krykbaeva M., Das J., Sarkar A., Gorman M.J., Fischinger S., et al. Fc Glycan-Mediated Regulation of Placental Antibody Transfer. Cell. 2019;178:202–215.e14. doi: 10.1016/j.cell.2019.05.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.05.044</ArticleId><ArticleId IdType="pmc">PMC6741440</ArticleId><ArticleId IdType="pubmed">31204102</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerman M.E., Crispin M., Yu X., Baruah K., Boesch A.W., Harvey D.J., Dugast A.S., Heizen E.L., Ercan A., Choi I., et al. Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J. Clin. Investig. 2013;123:2183–2192. doi: 10.1172/JCI65708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI65708</ArticleId><ArticleId IdType="pmc">PMC3637034</ArticleId><ArticleId IdType="pubmed">23563315</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahan A.E., Jennewein M.F., Suscovich T., Dionne K., Tedesco J., Chung A.W., Streeck H., Pau M., Schuitemaker H., Francis D., et al. Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination. PLoS Pathog. 2016;12:e1005456. doi: 10.1371/journal.ppat.1005456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005456</ArticleId><ArticleId IdType="pmc">PMC4794126</ArticleId><ArticleId IdType="pubmed">26982805</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung S., Quarmby V., Gao X., Ying Y., Lin L., Reed C., Fong C., Lau W., Qiu Z.J., Shen A., et al. Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcgamma receptor binding and antibody-dependent cell-mediated cytotoxicity activities. MAbs. 2012;4:326–340. doi: 10.4161/mabs.19941.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/mabs.19941</ArticleId><ArticleId IdType="pmc">PMC3355491</ArticleId><ArticleId IdType="pubmed">22531441</ArticleId></ArticleIdList></Reference><Reference><Citation>Falconer D.J., Subedi G.P., Marcella A.M., Barb A.W. Antibody Fucosylation Lowers the FcgammaRIIIa/CD16a Affinity by Limiting the Conformations Sampled by the N162-Glycan. ACS Chem. Biol. 2018;13:2179–2189. doi: 10.1021/acschembio.8b00342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.8b00342</ArticleId><ArticleId IdType="pmc">PMC6415948</ArticleId><ArticleId IdType="pubmed">30016589</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T., DiLillo D.J., Bournazos S., Giddens J.P., Ravetch J.V., Wang L.X. Modulating IgG effector function by Fc glycan engineering. Proc. Natl. Acad. Sci. USA. 2017;114:3485–3490. doi: 10.1073/pnas.1702173114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1702173114</ArticleId><ArticleId IdType="pmc">PMC5380036</ArticleId><ArticleId IdType="pubmed">28289219</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez D.R., Fong Y., Li S.H., Yang F., Jennewein M.F., Weiner J.A., Harrell E.A., Mangold J.F., Goswami R., Seage G.R., 3rd, et al. Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women. Cell. 2019;178:190–201.e11. doi: 10.1016/j.cell.2019.05.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.05.046</ArticleId><ArticleId IdType="pmc">PMC6727200</ArticleId><ArticleId IdType="pubmed">31204101</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor S.A., Sharma S., Remmel C.A.L., Holder B., Jones C.E., Marchant A., Ackerman M.E. HIV-Associated Alterations of the Biophysical Features of Maternal Antibodies Correlate With Their Reduced Transfer Across the Placenta. J. Infect. Dis. 2022;226:1441–1450. doi: 10.1093/infdis/jiac222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac222</ArticleId><ArticleId IdType="pmc">PMC9574667</ArticleId><ArticleId IdType="pubmed">35668706</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudley D.M., Van Rompay K.K., Coffey L.L., Ardeshir A., Keesler R.I., Bliss-Moreau E., Grigsby P.L., Steinbach R.J., Hirsch A.J., MacAllister R.P., et al. Miscarriage and stillbirth following maternal Zika virus infection in nonhuman primates. Nat. Med. 2018;24:1104–1107. doi: 10.1038/s41591-018-0088-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0088-5</ArticleId><ArticleId IdType="pmc">PMC6082723</ArticleId><ArticleId IdType="pubmed">29967348</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisher S.H., Balalian A.A., Reinebrant H., Shiau S., Flenady V., Kuhn L., Morse S.S. Systematic review: Fetal death reporting and risk in Zika-affected pregnancies. Trop. Med. Int. Health. 2021;26:133–145. doi: 10.1111/tmi.13522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tmi.13522</ArticleId><ArticleId IdType="pubmed">33164278</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch A.J., Roberts V.H.J., Grigsby P.L., Haese N., Schabel M.C., Wang X., Lo J.O., Liu Z., Kroenke C.D., Smith J.L., et al. Zika virus infection in pregnant rhesus macaques causes placental dysfunction and immunopathology. Nat. Commun. 2018;9:263. doi: 10.1038/s41467-017-02499-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02499-9</ArticleId><ArticleId IdType="pmc">PMC5772047</ArticleId><ArticleId IdType="pubmed">29343712</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro C.F., Lopes V.G.S., Brasil P., Pires A.R.C., Rohloff R., Nogueira R.M.R. Dengue infection in pregnancy and its impact on the placenta. Int. J. Infect. Dis. 2017;55:109–112. doi: 10.1016/j.ijid.2017.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2017.01.002</ArticleId><ArticleId IdType="pubmed">28088588</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabata T., Petitt M., Zydek M., Fang-Hoover J., Larocque N., Tsuge M., Gormley M., Kauvar L.M., Pereira L. Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placenta. J. Virol. 2015;89:5134–5147. doi: 10.1128/JVI.03674-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03674-14</ArticleId><ArticleId IdType="pmc">PMC4403461</ArticleId><ArticleId IdType="pubmed">25741001</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira L., Tabata T., Petitt M., Fang-Hoover J. Congenital cytomegalovirus infection undermines early development and functions of the human placenta. Placenta. 2017;59((Suppl. S1)):S8–S16. doi: 10.1016/j.placenta.2017.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2017.04.020</ArticleId><ArticleId IdType="pubmed">28477968</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrido-Pontnou M., Navarro A., Camacho J., Crispi F., Alguacil-Guillen M., Moreno-Baro A., Hernandez-Losa J., Sese M., Ramon Y.C.S., Garcia Ruiz I., et al. Diffuse trophoblast damage is the hallmark of SARS-CoV-2-associated fetal demise. Mod. Pathol. 2021;34:1704–1709. doi: 10.1038/s41379-021-00827-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-021-00827-5</ArticleId><ArticleId IdType="pmc">PMC8130566</ArticleId><ArticleId IdType="pubmed">34006935</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouachba A., Allias F., Nadaud B., Massardier J., Mekki Y., Bouscambert Duchamp M., Fourniere B., Huissoud C., Trecourt A., Collardeau-Frachon S. Placental lesions and SARS-CoV-2 infection: Diffuse placenta damage associated to poor fetal outcome. Placenta. 2021;112:97–104. doi: 10.1016/j.placenta.2021.07.288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2021.07.288</ArticleId><ArticleId IdType="pmc">PMC8280612</ArticleId><ArticleId IdType="pubmed">34329973</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz D.A., Morotti D. Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2. Viruses. 2020;12:1308. doi: 10.3390/v12111308.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12111308</ArticleId><ArticleId IdType="pmc">PMC7697563</ArticleId><ArticleId IdType="pubmed">33203131</ArticleId></ArticleIdList></Reference><Reference><Citation>Crocker I.P., Tanner O.M., Myers J.E., Bulmer J.N., Walraven G., Baker P.N. Syncytiotrophoblast degradation and the pathophysiology of the malaria-infected placenta. Placenta. 2004;25:273–282. doi: 10.1016/j.placenta.2003.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2003.09.010</ArticleId><ArticleId IdType="pubmed">15028419</ArticleId></ArticleIdList></Reference><Reference><Citation>Poovassery J., Moore J.M. Murine malaria infection induces fetal loss associated with accumulation of Plasmodium chabaudi AS-infected erythrocytes in the placenta. Infect. Immun. 2006;74:2839–2848. doi: 10.1128/IAI.74.5.2839-2848.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.74.5.2839-2848.2006</ArticleId><ArticleId IdType="pmc">PMC1459757</ArticleId><ArticleId IdType="pubmed">16622222</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogerson S.J., Pollina E., Getachew A., Tadesse E., Lema V.M., Molyneux M.E. Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes. Am. J. Trop. Med. Hyg. 2003;68:115–119. doi: 10.4269/ajtmh.2003.68.1.0680115.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2003.68.1.0680115</ArticleId><ArticleId IdType="pubmed">12556159</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma L., Kaur J., Shukla G. Role of oxidative stress and apoptosis in the placental pathology of Plasmodium berghei infected mice. PLoS ONE. 2012;7:e32694. doi: 10.1371/journal.pone.0032694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032694</ArticleId><ArticleId IdType="pmc">PMC3291651</ArticleId><ArticleId IdType="pubmed">22396790</ArticleId></ArticleIdList></Reference><Reference><Citation>Manicklal S., Emery V.C., Lazzarotto T., Boppana S.B., Gupta R.K. The "silent" global burden of congenital cytomegalovirus. Clin. Microbiol. Rev. 2013;26:86–102. doi: 10.1128/CMR.00062-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00062-12</ArticleId><ArticleId IdType="pmc">PMC3553672</ArticleId><ArticleId IdType="pubmed">23297260</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira L. Congenital Viral Infection: Traversing the Uterine-Placental Interface. Annu. Rev. Virol. 2018;5:273–299. doi: 10.1146/annurev-virology-092917-043236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-092917-043236</ArticleId><ArticleId IdType="pubmed">30048217</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan G., Hemmings D.G., Yurochko A.D., Guilbert L.J. Human cytomegalovirus-caused damage to placental trophoblasts mediated by immediate-early gene-induced tumor necrosis factor-alpha. Am. J. Pathol. 2002;161:1371–1381. doi: 10.1016/S0002-9440(10)64413-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)64413-6</ArticleId><ArticleId IdType="pmc">PMC1867293</ArticleId><ArticleId IdType="pubmed">12368210</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan G., Guilbert L.J. Ultraviolet-inactivated human cytomegalovirus induces placental syncytiotrophoblast apoptosis in a Toll-like receptor-2 and tumour necrosis factor-alpha dependent manner. J. Pathol. 2006;210:111–120. doi: 10.1002/path.2025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2025</ArticleId><ArticleId IdType="pubmed">16826536</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhuri S., Lowen B., Chan G., Davey A., Riddell M., Guilbert L.J. Human cytomegalovirus interacts with toll-like receptor 2 and CD14 on syncytiotrophoblasts to stimulate expression of TNFalpha mRNA and apoptosis. Placenta. 2009;30:994–1001. doi: 10.1016/j.placenta.2009.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2009.09.001</ArticleId><ArticleId IdType="pubmed">19796811</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins L., Vause S., Tower C. Cytomegalovirus infection in association with early onset pre-eclampsia. BMJ Case Rep. 2010;2010:bcr0320102803. doi: 10.1136/bcr.03.2010.2803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr.03.2010.2803</ArticleId><ArticleId IdType="pmc">PMC3030220</ArticleId><ArticleId IdType="pubmed">22789552</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmes E.C., Li S.H., Hurst J.H., Yang Z., Niedzwiecki D., Fouda G.G., Kurtzberg J., Walsh K.M., Permar S.R. Congenital Human Cytomegalovirus Infection Is Associated With Decreased Transplacental IgG Transfer Efficiency Due to Maternal Hypergammaglobulinemia. Clin. Infect. Dis. 2022;74:1131–1140. doi: 10.1093/cid/ciab627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab627</ArticleId><ArticleId IdType="pmc">PMC8994583</ArticleId><ArticleId IdType="pubmed">34260701</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharps M.C., Hayes D.J.L., Lee S., Zou Z., Brady C.A., Almoghrabi Y., Kerby A., Tamber K.K., Jones C.J., Adams Waldorf K.M., et al. A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection. Placenta. 2020;101:13–29. doi: 10.1016/j.placenta.2020.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2020.08.018</ArticleId><ArticleId IdType="pmc">PMC7443324</ArticleId><ArticleId IdType="pubmed">32911234</ArticleId></ArticleIdList></Reference><Reference><Citation>Shook L.L., Brigida S., Regan J., Flynn J.P., Mohammadi A., Etemad B., Siegel M.R., Clapp M.A., Li J.Z., Roberts D.J., et al. SARS-CoV-2 Placentitis Associated With B.1.617.2 (Delta) Variant and Fetal Distress or Demise. J. Infect. Dis. 2022;225:754–758. doi: 10.1093/infdis/jiac008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac008</ArticleId><ArticleId IdType="pmc">PMC8807229</ArticleId><ArticleId IdType="pubmed">35024844</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz D.A. Stillbirth after COVID-19 in Unvaccinated Mothers Can Result from SARS-CoV-2 Placentitis, Placental Insufficiency, and Hypoxic Ischemic Fetal Demise, Not Direct Fetal Infection: Potential Role of Maternal Vaccination in Pregnancy. Viruses. 2022;14:458. doi: 10.3390/v14030458.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14030458</ArticleId><ArticleId IdType="pmc">PMC8950737</ArticleId><ArticleId IdType="pubmed">35336864</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz D.A., Avvad-Portari E., Babál P., Baldewijns M., Blomberg M., Bouachba A., Camacho J., Collardeau-Frachon S., Colson A., Dehaene I., et al. Placental Tissue Destruction and Insufficiency From COVID-19 Causes Stillbirth and Neonatal Death From Hypoxic-Ischemic Injury: A Study of 68 Cases with SARS-CoV-2 Placentitis from 12 Countries. Arch. Pathol. Lab. Med. 2022;146:660–676. doi: 10.5858/arpa.2022-0029-SA.</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2022-0029-SA</ArticleId><ArticleId IdType="pubmed">35142798</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean A.R.D., Stanisic D., McGready R., Chotivanich K., Clapham C., Baiwog F., Pimanpanarak M., Siba P., Mueller I., King C.L., et al. P. falciparum infection and maternofetal antibody transfer in malaria-endemic settings of varying transmission. PLoS ONE. 2017;12:e0186577. doi: 10.1371/journal.pone.0186577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186577</ArticleId><ArticleId IdType="pmc">PMC5640245</ArticleId><ArticleId IdType="pubmed">29028827</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikumi N.M., Matjila M., Gray C.M., Anumba D., Pillay K. Placental pathology in women with HIV. Placenta. 2021;115:27–36. doi: 10.1016/j.placenta.2021.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2021.09.006</ArticleId><ArticleId IdType="pubmed">34537469</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox C.R., Holder B., Jones C.E. Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy. Front. Immunol. 2017;8:1294. doi: 10.3389/fimmu.2017.01294.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01294</ArticleId><ArticleId IdType="pmc">PMC5671757</ArticleId><ArticleId IdType="pubmed">29163461</ArticleId></ArticleIdList></Reference><Reference><Citation>Massonnet B., Delwail A., Ayrault J.M., Chagneau-Derrode C., Lecron J.C., Silvain C. Increased immunoglobulin A in alcoholic liver cirrhosis: Exploring the response of B cells to Toll-like receptor 9 activation. Clin. Exp. Immunol. 2009;158:115–124. doi: 10.1111/j.1365-2249.2009.04004.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2009.04004.x</ArticleId><ArticleId IdType="pmc">PMC2759066</ArticleId><ArticleId IdType="pubmed">19737238</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe N., Kobayashi M., Shigeta Y., Hara H. Chronic idiopathic neutropenia with hypergammaglobulinemia. Jpn. J. Med. 1987;26:65–68. doi: 10.2169/internalmedicine1962.26.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine1962.26.65</ArticleId><ArticleId IdType="pubmed">3494873</ArticleId></ArticleIdList></Reference><Reference><Citation>Nocturne G., Mariette X. B cells in the pathogenesis of primary Sjogren syndrome. Nat. Rev. Rheumatol. 2018;14:133–145. doi: 10.1038/nrrheum.2018.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2018.1</ArticleId><ArticleId IdType="pubmed">29416129</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel S.M., Jallow S., Boiditswe S., Madhi S.A., Feemster K.A., Steenhoff A.P., Arscott-Mills T., Muthoga C., Ajibola G., Shapiro R., et al. Placental Transfer of Respiratory Syncytial Virus Antibody Among HIV-Exposed, Uninfected Infants. J. Pediatr. Infect. Dis. Soc. 2020;9:349–356. doi: 10.1093/jpids/piz056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piz056</ArticleId><ArticleId IdType="pmc">PMC7358043</ArticleId><ArticleId IdType="pubmed">31549157</ArticleId></ArticleIdList></Reference><Reference><Citation>Baroncelli S., Maria Galluzzo C., Liotta G., Orlando S., Ciccacci F., Andreotti M., Mpwhere R., Luhanga R., Sagno J.B., Amici R., et al. IgG abnormalities in HIV-positive Malawian women initiating antiretroviral therapy during pregnancy persist after 24 months of treatment. Int. J. Infect. Dis. 2019;88:1–7. doi: 10.1016/j.ijid.2019.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2019.09.001</ArticleId><ArticleId IdType="pubmed">31499207</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosire R., Farquhar C., Nduati R., Broliden K., Luchters S., Van de Perre P., De Vincenzi I., Merkel M., Wachuka V., Mbori-Ngacha D., et al. Higher Transplacental Pathogen-Specific Antibody Transfer Among Pregnant Women Randomized to Triple Antiretroviral Treatment Versus Short Course Zidovudine. Pediatr. Infect. Dis. J. 2018;37:246–252. doi: 10.1097/INF.0000000000001749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000001749</ArticleId><ArticleId IdType="pmc">PMC5807132</ArticleId><ArticleId IdType="pubmed">28834955</ArticleId></ArticleIdList></Reference><Reference><Citation>Modjarrad K., Giersing B., Kaslow D.C., Smith P.G., Moorthy V.S., WHO RSV Vaccine Consultation Expert Group WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015. Vaccine. 2016;34:190–197. doi: 10.1016/j.vaccine.2015.05.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.05.093</ArticleId><ArticleId IdType="pmc">PMC6858870</ArticleId><ArticleId IdType="pubmed">26100926</ArticleId></ArticleIdList></Reference><Reference><Citation>Borowczak J., Gasiorek-Kwiatkowska A., Szczerbowski K., Maniewski M., Zdrenka M., Szadurska-Noga M., Gostomczyk K., Rutkiewicz P., Olejnik K., Cnota W., et al. SARS-CoV-2 Infection during Delivery Causes Histopathological Changes in the Placenta. Diseases. 2024;12:142. doi: 10.3390/diseases12070142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diseases12070142</ArticleId><ArticleId IdType="pmc">PMC11276080</ArticleId><ArticleId IdType="pubmed">39057113</ArticleId></ArticleIdList></Reference><Reference><Citation>Simioni C., Sanz J.M., Gafa R., Tagliatti V., Greco P., Passaro A., Neri L.M. Effects of SARS-CoV-2 on molecules involved in vascularization and autophagy in placenta tissues. J. Mol. Histol. 2024;55:753–764. doi: 10.1007/s10735-024-10228-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10735-024-10228-y</ArticleId><ArticleId IdType="pmc">PMC11464539</ArticleId><ArticleId IdType="pubmed">39088116</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves J., Melro M., Alenquer M., Araujo C., Castro-Neves J., Amaral-Silva D., Ferreira F., Ramalho J.S., Charepe N., Serrano F., et al. Balance between maternal antiviral response and placental transfer of protection in gestational SARS-CoV-2 infection. JCI Insight. 2023;8:e167140. doi: 10.1172/jci.insight.167140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.167140</ArticleId><ArticleId IdType="pmc">PMC10544212</ArticleId><ArticleId IdType="pubmed">37490342</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>